137 related articles for article (PubMed ID: 1414338)
1. Disseminated intravascular coagulation syndrome in anorexia nervosa.
Katamura K; Ishimoto F; Yamasaki M; Yoshimura M; Kisa T
Acta Paediatr Jpn; 1992 Aug; 34(4):469-72. PubMed ID: 1414338
[TBL] [Abstract][Full Text] [Related]
2. A case of anorexia nervosa with disseminated intravascular coagulation syndrome.
Haruta I; Asakawa A; Ogiso K; Amitani H; Amitani M; Tsai M; Hamada S; Inui A
Int J Eat Disord; 2012 Apr; 45(3):453-5. PubMed ID: 22407868
[TBL] [Abstract][Full Text] [Related]
3. [Intravascular coagulation in anorexia nervosa (author's transl)].
Sutor AH; Schütte B; Aschoff W; Niederhoff H; Künzer W
Dtsch Med Wochenschr; 1977 Oct; 102(41):1469-72. PubMed ID: 913280
[TBL] [Abstract][Full Text] [Related]
4. Gabexate mesilate (FOY) therapy of disseminated intravascular coagulation due to sepsis.
Taenaka N; Shimada Y; Hirata T; Nishijima MK; Takezawa J; Yoshiya I; Kambayashi J
Crit Care Med; 1983 Sep; 11(9):735-8. PubMed ID: 6411432
[TBL] [Abstract][Full Text] [Related]
5. Case report of cardiovascular abnormalities in anorexia nervosa.
Brotman AW; Stern TA
Am J Psychiatry; 1983 Sep; 140(9):1227-8. PubMed ID: 6614237
[TBL] [Abstract][Full Text] [Related]
6. Comparison of gabexate mesilate and nafamostat mesilate for disseminated intravascular coagulation associated with hematological malignancies.
Minakata D; Fujiwara SI; Ikeda T; Kawaguchi SI; Toda Y; Ito S; Ochi SI; Nagayama T; Mashima K; Umino K; Nakano H; Yamasaki R; Morita K; Kawasaki Y; Sugimoto M; Yamamoto C; Ashizawa M; Hatano K; Sato K; Oh I; Ohmine K; Muroi K; Ohmori T; Kanda Y
Int J Hematol; 2019 Feb; 109(2):141-146. PubMed ID: 30536180
[TBL] [Abstract][Full Text] [Related]
7. Treatment of disseminated intravascular coagulation with gabexate mesilate.
Tamaki S; Wada H; Hiyoyama K; Shimura M; Minamikawa K; Wakita Y; Nakase T; Ohiwa M; Kaneko T; Iwasaki E
Clin Ther; 1993; 15(6):1076-84. PubMed ID: 8111805
[TBL] [Abstract][Full Text] [Related]
8. [Disseminated intravascular coagulation].
Iba T; Kidokoro A
Nihon Rinsho; 2003 Jun; 61(6):1010-4. PubMed ID: 12806952
[TBL] [Abstract][Full Text] [Related]
9. [Evaluation of FOY therapy for DIC or pre-DIC associated with neurosurgical disease].
Wakui K; Takemae T; Kobayashi S
No Shinkei Geka; 1990 Jul; 18(7):609-17. PubMed ID: 2118601
[TBL] [Abstract][Full Text] [Related]
10. [Disseminated intravascular coagulation (DIC) following open heart surgery and great vessel surgery. The result of early administration of gabexate mesilate (FOY)].
Chihara K; Akiyama F; Shinozaki T; Shimamoto M; Takahashi K; Imura H; Yamazaki F; Kawarazaki S
Kyobu Geka; 1984 Aug; 37(8):606-13. PubMed ID: 6438381
[No Abstract] [Full Text] [Related]
11. Guidelines for the diagnosis and management of disseminated intravascular coagulation. British Committee for Standards in Haematology.
Levi M; Toh CH; Thachil J; Watson HG
Br J Haematol; 2009 Apr; 145(1):24-33. PubMed ID: 19222477
[TBL] [Abstract][Full Text] [Related]
12. Effects of antithrombin and gabexate mesilate on disseminated intravascular coagulation: a preliminary study.
Nishiyama T; Kohno Y; Koishi K
Am J Emerg Med; 2012 Sep; 30(7):1219-23. PubMed ID: 22204993
[TBL] [Abstract][Full Text] [Related]
13. [Synthetic protease inhibitors in the treatment of disseminated intravascular coagulation].
Aramoto H; Saito H; Shigematsu H; Muto T
Nihon Rinsho; 1993 Jan; 51(1):93-8. PubMed ID: 8433532
[TBL] [Abstract][Full Text] [Related]
14. [Therapy of disseminated intravascular coagulation in acute promyelocytic leukemias. Apropos of 19 cases].
Rodríguez Gómez M; López Fernández MF; Batlle J
Sangre (Barc); 1993 Dec; 38(6):449-53. PubMed ID: 8171380
[TBL] [Abstract][Full Text] [Related]
15. [Adult-onset Still disease presenting with disseminated intravascular coagulation].
Arai Y; Handa T; Mitani K
Rinsho Ketsueki; 2004 Apr; 45(4):316-8. PubMed ID: 15168449
[TBL] [Abstract][Full Text] [Related]
16. Alveolar rhabdomyosarcoma with massive disseminated intravascular coagulopathy treated with systemic chemotherapy.
Yoon BG; Baek HJ; Oh BS; Han DK; Choi YD; Kook H
Korean J Pediatr; 2015 Dec; 58(12):505-8. PubMed ID: 26770227
[TBL] [Abstract][Full Text] [Related]
17. Treatment of disseminated intravascular coagulation and its prodromal stage with gabaxate mesilate (FOY): a multi-center trial.
Okamura T; Niho Y; Itoga T; Chiba S; Miyake M; Kotsuru M; Saito H; Ichimaru M; Hara K; Takatsuki K
Acta Haematol; 1993; 90(3):120-4. PubMed ID: 8291369
[TBL] [Abstract][Full Text] [Related]
18. Gabexate as a therapy for disseminated intravascular coagulation.
Umeki S; Adachi M; Watanabe M; Yaji S; Soejima R
Arch Intern Med; 1988 Jun; 148(6):1409-12. PubMed ID: 3132124
[TBL] [Abstract][Full Text] [Related]
19. A retrospective comparative study of recombinant human thrombomodulin and gabexate mesilate in sepsis-induced disseminated intravascular coagulation patients.
Takazono T; Nakamura S; Imamura Y; Yoshioka S; Miyazaki T; Izumikawa K; Sawai T; Matsuo N; Yanagihara K; Suyama N; Kohno S
J Infect Chemother; 2014 Aug; 20(8):484-8. PubMed ID: 24855912
[TBL] [Abstract][Full Text] [Related]
20. Abdominal aortic aneurysm complicated with chronic disseminated intravascular coagulopathy: a case of surgical treatment.
Mukaiyama H; Shionoya S; Ikezawa T; Kamiya T; Hamaguchi M; Saito H
J Vasc Surg; 1987 Dec; 6(6):600-4. PubMed ID: 3121870
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
